The reduction in hypoglycaemic burden in our study was almost identical to that in Russell and colleagues' study,30 which compared 5 day use of a bihormonal (insulin and glucagon) closed-loop system with usual pump therapy in adults with type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.